Senology is fast becoming a medical specialty that utilises methods and knowledge from various medical disciplines specifically to treat breast cancer. Based in Dusseldorf, the European Academy of Senology (EAoS) aims to close the gap between theory and practical applications.
Among the most important EU guidelines for efficient breast cancer screening is the assumption that it is a low-threshold offer, which, after an initial start-up period, will include at least 70% of all women aged between 50 and 69. To ensure that this quota is met in areas that lack infrastructure, whilst also keeping personnel expenditure at bay, for the last few years mammobiles have toured…
Although breast cancer, the most common disease affecting women, accounts for over 30% of all the cancers they suffer (far ahead of colon, ovary or lung cancer), breast cancer is responsible for only 1% of cancer related deaths.
Not so long ago this country, of considerable linguistic division, was a split into three regions, referred to as Flemish (with five provinces), Walloon (with five provinces) and the Brussels Capital. Each has its own parliament, with governments responsible for their individual region's affairs; these include health. Dr Catherine Breucq, head of the Breast Imaging Department at Brussels…
Every year the German Society for Senology congress facilitates interdisciplinary breast cancer discussion between gynaecologists, radiologists, surgeons, pathologists, internists, radio-oncologists and plastic surgeons. In an interview with Karoline Laarmann, of European Hospital, radiologist Professor Ingrid Schreer (right), head of the Breast Centre at the University Women's Hospital in Kiel,…
Studies show promise for fast, 5-day therapy for early-stage breast cancer patients
The breast cancer risk of women who are regularly physically active in the postmenopausal phase is reduced by about one third compared to relatively inactive women, according to a study conducted by the German Cancer Research Centre (Deutsches Krebsforschungszentrum, DKFZ) and the University Hospitals of Hamburg-Eppendorf.
Arriving at the Austrian Congress Center in Vienna, a pink truck is striking the eyes of the visitors of ECR. The truck took the long way from Belgium to Austria to demonstrate a pretty successful project of the University Hospital Brussels: A mobile mammography unit that examines women living in rural areas and who otherwise would probably not join the screening programm. The trailer was…
Within the last three decades, contrast-enhanced magnetic resonance breast imaging has gone through substantial developments, evolving to become the imaging modality with the highest sensitivity for breast cancer detection. The indication to perform breast MRI ranges widely, including high-risk patients, dense breast tissue and therapy monitoring under primary systemic therapy.
The diagnostic use of ultrasound has improved significantly because of improved resolution and reduction in artifacts, allowing increasingly more specific examination.
Dr Giorgio Rizzatto, who heads the Department of Diagnostic Imaging at ASS 2 Isontina (including the Gorizia and Monfalcone hospitals) in NE Italy, works with nine radiologists, who examine and report on 80,000 clinical and screening breast examinations annually.
The Dutch screening programme, which began in 1990, invites women aged 50-75 years for mammography screening every two years. Today, the national programme is undergoing considerable regional re-organisation. As one of a team of 12 radiologists at the Alkmaar Medical Centre, Dr Shirley Go is responsible for Mammography and Screening in a large Dutch region. Daniela Zimmermann, asked Dr Go about…
Big discussions are expected at the upcoming European Association of Urology (EAU) Congress in Stockholm* when urologist Dr Jochen Walz (right), of the Urological Department at the Institute Paoli-Calmettes, Marseilles, France, presents the forum: Imaging in Europe: Who, where, what, how many! and M F Coelho, of the European Society of Urological Imaging (ESUI) describes the Clinical utility of…
Siemens Healthcare recently presented its first MRI breast scanner, Magnetom Espree-Pink. The 1.5-Tesla system is the latest innovation in magnetic resonance imaging, featuring a dedicated solution for breast examinations. Particularly for obese and claustrophobic patients, the large, 70-centimeter magnet bore makes examinations more comfortable, or, in some cases, it makes them possible for the…
Carestream Health installed its two thousandth high-resolution CR system for mammography at the Rechts der Isar Clinic in Munich, Germany. The company's CR Mammography Feature which enables mammography images to be captured digitally while utilizing a healthcare provider's existing mammography x-ray unit and workflow processes is intended for use in the same clinical and screening applications…
Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
The Acuson S2000 Automated Breast Volume Scanner (ABVS) system automatically and quickly acquires full-field sonographic volumes for comprehensive review and diagnosis of the breast streamlining workflow and reducing operator dependence and variability.
Siemens Healthcare has opened a new research centre in Cologne, where around 40 employees are developing new diagnostic tests to describe the molecular characteristics of breast cancer cells, to help physicians to select individual therapy.
Professor Friedrich Degenhardt (right), Head of the Gynaecology Clinic at Franziskus Hospital, Bielefeld and the Cooperative Breast Centre Bielefeld-Herford, Germany, is using elastosonography to examine breast carcinomas. We asked him to outline present finding as to its value, future potential, and the current value of ultrasound in breast cancer detection.
In a pre-conference discussion with this year's President, Professor Hans-Heinrich Kreipe, Director of the Institute for Pathology at Hanover Medical School, he outlined the significance of MRI in breast cancer detection, and highlighted other topics for the event.
'Diagnostics is not diagnostics, not even when it relates to a specific indication such as breast cancer,' says Professor Walter Heindel MD (right), who heads the Munster Mammography and Breast Centre Reference Centre at Munster University Hospital, focusing on the dissimilarities among patient groups and their peculiarities.
If, in the early days of mammary sonography, it was revealed to be helpful to render tactual findings in a visible manner (sonic palpation), then now is the time to palpate clinically occult findings in a new manner (Elastoscan*).
German scientist Harald zur Hausen showed that oncogenic human papilloma virus (HPV) cause cervical cancer, the second most common cancer among women. Françoise Barré-Sinoussi and Luc Montagnier from France discovered HIV.
Fighting breast cancer is always a race against time - early detection of breast carcinoma an essential condition for cure. Now Scientists from Finland, Germany and France developed a promising new CT technique with high resolution and contrast that visualises tumours that are even diffusely growing or those in dense breasts.
“Molecular breast imaging” (MBI), a new scintigraphy method developed by US researchers, might improve early detection of breast cancer in women with dense breasts. The results of an initial clinical study were recently presented at the Breast Cancer Symposium of the American Society of Clinical Oncology (ASCO) in Washington, DC, USA.
